Mouse Models for Elastic Fiber Diseases
Mouse Models for Elastic Fiber Diseases
批准号:
7740741
负责人:
MON-LI H. CHU
金额:
$20.86万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-01 至 2011-06-30
关键词:
18 year old2 year oldAffectAllelesAmino Acid SequenceAmino AcidsAneurysmAnimal ModelAortic AneurysmArchitectureArteriesBiocompatible MaterialsBlood VesselsBreedingCalcium BindingCardiovascular systemClinicalComplexConnective TissueCutaneousCutis LaxaDefectDegenerative DisorderDiseaseElastic CartilageElastic FiberEmbryonic DevelopmentEpidermal Growth FactorEtiologyExtracellular MatrixExtracellular Matrix ProteinsFBN1FemaleFractureFunctional disorderFutureGene TargetingGenerationsGeneticGerm LinesGoalsGrantGrowth FactorHomeostasisHumanJoint LaxityLigamentsLungMissense MutationModelingMolecularMusMutant Strains MiceMutationNIH Program AnnouncementsOrganOsteoporosisPathogenesisPatientsPhenotypePropertyProteinsPulmonary EmphysemaPulmonary artery structureResearchRisk FactorsSignal PathwaySignal TransductionSkinSystemTendon structureTropoelastinVariantage relatedanimal model developmentartery stenosisbasebody systemembryonic stem cellextracellularfibulin-4girlshomologous recombinationhuman diseasein vivoinsightmouse modelmutantnovelpublic health relevanceresponseskeletalskeletal abnormalitytherapeutic developmenttherapeutic evaluationtransmission process
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The goal of this grant is to generate new mouse models for human diseases of the elastic fiber system. Quantitative and qualitative changes in the extracellular elastic fiber network are known to be associated with a range of congenital and degenerative conditions affecting the cardiovascular, pulmonary, skeletal, ocular and cutaneous systems. The extracellular matrix protein fibulin-4 has recently emerged as a molecule that is essential for elastic fiber assembly. This protein interacts with tropoelastin and fibrillin-1, and its deficiency results in impaired elastic fiber formation and increased TGF-2 signaling in mice. Recently, missense mutations in fibulin-4 have been identified in human patients with clinical manifestations of aortic aneurysm, pulmonary artery stenosis, tortuous arteries, emphysema, congenital bone fractures, joint laxity and cutis laxa. These findings suggest that fibulin-4 is pleiotropic with widespread effects, and that amino acid variations in fibulin-4 may be risk factors for complex diseases, such as aneurysm, emphysema and osteoporosis. This application proposes to generate two mouse models harboring different missense fibulin-4 mutations recently identified in patients. The missense mutations will be introduced into mouse embryonic stem cells, which will be used to generate heterozygous and then homozygous mouse mutants. These models will facilitate a deeper understanding of the molecular basis and pathogenesis of diseases resulting from fibulin-4 missense mutations. The mouse mutants can be bred with mouse models of other elastic fiber components in the future, thereby enabling studies of differential and overlapping functions served by fibulin-4 and other key elastic fiber components. The mouse models will also provide novel insights into the etiology and pathogenesis of complex diseases associated with elastic fiber dysfunction. Availability of these mouse models is central to the evaluation of therapeutic strategies for elastic fiber diseases. PUBLIC HEALTH RELEVANCE: This application proposes to generate mouse models for human diseases of the elastic fiber system. Defects in elastic fibers of the connective tissue can result in aortic aneurysm, lung emphysema, bone fractures and loose skin. Generation of mouse models is central to the development of therapeutic treatment for these disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mouse Models for Elastic Fiber Diseases
-
批准号:7866691
-
项目类别:
-
资助金额:$17.21万
-
财政年份:2009
-
负责人:MON-LI H. CHU
-
依托单位:
Ullrich Syndrome: Pathogenesis and Therapies
-
批准号:7274779
-
项目类别:
-
资助金额:$32.33万
-
财政年份:2005
-
负责人:MON-LI H. CHU
-
依托单位:
Ullrich Syndrome: Pathogenesis and Therapies
-
批准号:7125995
-
项目类别:
-
资助金额:$33.3万
-
财政年份:2005
-
负责人:MON-LI H. CHU
-
依托单位:
Ullrich Syndrome: Pathogenesis and Therapies
-
批准号:7468046
-
项目类别:
-
资助金额:$31.69万
-
财政年份:2005
-
负责人:MON-LI H. CHU
-
依托单位:
Ullrich Syndrome: Pathogenesis and Therapies
-
批准号:7022094
-
项目类别:
-
资助金额:$34.28万
-
财政年份:2005
-
负责人:MON-LI H. CHU
-
依托单位:
Ullrich Syndrome: Pathogenesis and Therapies
-
批准号:7671459
-
项目类别:
-
资助金额:$31.69万
-
财政年份:2005
-
负责人:MON-LI H. CHU
-
依托单位:
Zinc Finger Protein Zac1 and Chondrogenesis
-
批准号:6729826
-
项目类别:
-
资助金额:$7.85万
-
财政年份:2003
-
负责人:MON-LI H. CHU
-
依托单位:
Zinc Finger Protein Zac1 and Chondrogenesis
-
批准号:6803601
-
项目类别:
-
资助金额:$7.85万
-
财政年份:2003
-
负责人:MON-LI H. CHU
-
依托单位:
CORE--MOLECULAR BIOLOGY
-
批准号:6299820
-
项目类别:
-
资助金额:$14.48万
-
财政年份:1999
-
负责人:MON-LI H. CHU
-
依托单位:
CORE--MOLECULAR BIOLOGY
-
批准号:6100441
-
项目类别:
-
资助金额:$14.48万
-
财政年份:1998
-
负责人:MON-LI H. CHU
-
依托单位:
FUNCTION OF EXTRACELLULAR MATRIX PROTEIN FIBULIN 2
-
批准号:2701814
-
项目类别:
-
资助金额:$22.69万
-
财政年份:1997
-
负责人:MON-LI H. CHU
-
依托单位:
Function of Fibulins
-
批准号:6331026
-
项目类别:
-
资助金额:$29.56万
-
财政年份:1997
-
负责人:MON-LI H. CHU
-
依托单位:
Function of Fibulins
-
批准号:6607152
-
项目类别:
-
资助金额:$29.85万
-
财政年份:1997
-
负责人:MON-LI H. CHU
-
依托单位:
CORE--MOLECULAR BIOLOGY
-
批准号:6268356
-
项目类别:
-
资助金额:$14.09万
-
财政年份:1997
-
负责人:MON-LI H. CHU
-
依托单位:
FUNCTION OF EXTRACELLULAR MATRIX PROTEIN FIBULIN 2
-
批准号:2024179
-
项目类别:
-
资助金额:$22.1万
-
财政年份:1997
-
负责人:MON-LI H. CHU
-
依托单位:
FUNCTION OF EXTRACELLULAR MATRIX PROTEIN FIBULIN 2
-
批准号:2910304
-
项目类别:
-
资助金额:$23.36万
-
财政年份:1997
-
负责人:MON-LI H. CHU
-
依托单位:
Function of Fibulins
-
批准号:6757826
-
项目类别:
-
资助金额:$29.85万
-
财政年份:1997
-
负责人:MON-LI H. CHU
-
依托单位:
Function of Fibulins
-
批准号:6519806
-
项目类别:
-
资助金额:$29.85万
-
财政年份:1997
-
负责人:MON-LI H. CHU
-
依托单位:
FUNCTION OF EXTRACELLULAR MATRIX PROTEIN FIBULIN 2
-
批准号:6180694
-
项目类别:
-
资助金额:$24.05万
-
财政年份:1997
-
负责人:MON-LI H. CHU
-
依托单位:
CORE--MOLECULAR BIOLOGY
-
批准号:6235720
-
项目类别:
-
资助金额:$6.78万
-
财政年份:1996
-
负责人:MON-LI H. CHU
-
依托单位:
海外基金